W. Kang

Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP.

Yung‐Jue Bang, Farzaneh Pirnia, Wen‐Ning Fang et al. · Proceedings of the National Academy of Sciences · 1994 · 246 citations

Urology, Developmental Biology, Signal Transduction +13

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer

Seong Hoon Lim, Tae Won Kim, Yuancheng Hong et al. · British Journal of Cancer · 2015 · 86 citations · Full text

Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens

Yoon‐Koo Kang, W. Kang, Maria Di Bartolomeo et al. · Annals of Oncology · 2019 · 71 citations · Full text

Oncology, Gastrointestinal Oncology, Cancer Management +8

Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma

Jung Ho Kim, H. Y. Kim, Chul Won Jung et al. · Journal of Clinical Oncology · 2005 · 38 citations

Renal Pathology, Pathology, Somatic Vhl Alterations +19

Gastric GIST: A single institutional retrospective experience with surgical treatment for primary disease

Ji Yeong An, Min Gew Choi, Jung Hyun Noh et al. · European Journal of Surgical Oncology · 2007 · 35 citations

Primary Disease, Surgical Treatment, Gastroenterology +9